DHL Supply Chain, which provides contract logistics in North America, has agreed to acquire SDS Rx, a provider of final-mile delivery and specialized healthcare transportation for long-term care and specialty pharmacies, radiopharmacies and health system networks.

DHL said in a September 9 statement that the acquisition will expand DHL’s healthcare logistics portfolio.

Processing specialized healthcare deliveries from more than 200 locations across the U.S., SDS Rx will add final-mile logistics services to DHL’s healthcare transportation network. DHL said the acquisition will also expand DHL’s same-day and expedited delivery capabilities for life sciences and healthcare customers.

“The increasing demand for specialty pharma and healthcare solutions presents significant opportunities for DHL to leverage its scale, expertise, and commitment to operational excellence,” said Mark Kunar, CEO of DHL Supply Chain North America.

Drew Kronick, Founder, CEO & managing partner of SDS Rx said, “As the demand for last mile delivery in healthcare continues to grow, we understand the importance of aligning with a partner who shares our patient-first commitment.”

Read More: Climate Change Exposes Weak Links in U.S. Medical Supply Chains

This will be the second healthcare acquisition for DHL Supply Chain in 2025, following its purchase of CryoPDP, a leading specialty courier focused on clinical trials, biopharmaceuticals as well as cell and gene therapies, earlier this year. 

The closing of the acquisition is subject to regulatory approvals.